Dr. Jeffrey T. Rado, MD

Dr. Rado practices at Northwestern Medicine Dialysis Center in Chicago, Illinois.

Dr. Rado's NPI, 1881706455, was assigned on August 31, 2006. Dr. Rado holds Illinois license 036107950.

Dr. Rado's primary practice is Northwestern Medicine Dialysis Center, at 676 N St Clair St 20th Fl Ste 2020, Chicago, IL 60611 in Cook County. The practice phone is (312) 472-5200.

Dr. Rado's primary practice is Northwestern Medicine Dialysis Center in Chicago, Illinois. Dr. Rado is also affiliated with Northwestern Memorial Hospital. The medical group on file is Northwestern Medical Faculty Foundation. Dmand AI also links Dr. Rado to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account. Dr. Rado's employer is on file too: a dialysis center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rado practices, 5 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Rado's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Rado is licensed in Illinois.

CMS data shows 428 Medicare services from Dr. Rado across 5 procedure codes in 2024, for 93 Medicare patients. Medicare paid $28,582 for them. Every service was in an office.

CMS counts 93 Medicare patients who saw Dr. Rado in 2024. The largest group is under 65, with 38 patients. 75% of them have mood disorders, and 73% have anxiety. 39% are also on Medicaid. Their average risk score is 1.46, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rado's median patient age at 52, with 51% women.

In 2024, Dr. Rado wrote 1,486 Medicare Part D claims for 86 patients. 94% of them were for generic drugs. CMS names the drug for 1,318 of them, across 31 drugs with 11 or more claims each, at $102,134 in total drug cost. In 2023, CMS named 1,419 claims across 33 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Rado for performance year 2024, reported through an alternative payment model (APM). Dr. Rado accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rado as offering telehealth.

Dmand AI links 15 papers to Dr. Rado, published from 2010 to 2024. 2021 was the busiest year, with 2. The most frequent topics are Antipsychotic Agents, Primary Health Care and Schizophrenia. Dr. Rado has published most often in Expert Opin Pharmacother. Dr. Rado's most frequent co-authors are Jane P. Gagliardi, MD, Thomas W. Heinrich, MD and Heather Chienyu Huang, MD.

Dmand AI links Dr. Rado to 1 clinical trial. Conditions studied include Schizophrenia and Schizophrenia Spectrum and Other Psychotic Disorders. Open Payments lists research payments to Dr. Rado that name 1 trial.

CMS Open Payments shows 261 general payments to Dr. Rado from 13 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 60% of the total. Alkermes, Inc. paid the most, $170,419. It also lists 24 research payments totaling $2,270 in 2018, naming 1 clinical trial.